Litigating Civil Antitrust Matters In The United States

Publisher: Matthew Bender

Select a format

Print Book :Print Book
ISBN: 9781632829764
In Stock
Price
$277.00
QTY
eBook :epub
ISBN: 9781632829757
In Stock
Price
$277.00
QTY
eBook :mobi
ISBN: 9781632829757
In Stock
Price
$277.00
QTY
International Order Inquiry

Product details

View a sample of this title using the ReadNow feature

This book offers both lawyer and non-lawyer the opportunity to understand the various types of civil antitrust litigation that is active in the United States. The book is organized by legal theory and starts with by addressing the most common type of antitrust litigation, which is litigation arising under Section 1 of the Sherman Act. The book then addresses Section 2 (monopolies) and the Robinson-Patman Act, before devoting two chapters to the intersection of antitrust and intellectual property, both generally and specifically with respect to the pharmaceutical industry. The book concludes by addressing issues associated with litigating civil antitrust claims brought by the federal government.

The focus is on trying to make the chapters easy to read while still providing sufficient case citations so that a lawyer who wishes to pursue a more in-depth focus on a topic would have the leading cases at his or her disposal. The book will be updated in order to account for new developments in the law.

Table of Contents

•  Chapter 1 - Sherman Act 1 Claims 

•  Chapter 2 - Sherman Act 2 Claims

•  Chapter 3 - The Robinson-Patman Act

•  Chapter 4 - Antitrust Class Actions

•  Chapter 5 - Antitrust Issues Raised by the Assertion of Intellectual Property Rights

•  Chapter 6 - Pharmaceutical Antitrust: Rethinking First Principles in the Context of Hatch-Waxman

•  Chapter 7 - Litigating Against the Government